Journals Library

An error occurred retrieving publication content to display, please try again.

Page not found (404)

Sorry - the page you requested could not be found.

Please choose a page from the navigation or try a website search above to find the information you need.

Study found that, despite some concerns, the use of neuraminidase inhibitors in at-risk populations appeared to be a cost-effective approach for the treatment of influenza, and when data were available for adverse events and complication rates, there was little overall difference associated with the use of either zanamivir or oseltamivir when compared individually with placebo

{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

J Burch, M Paulden, S Conti, C Stock, M Corbett, NJ Welton, AE Ades, A Sutton, N Cooper, AJ Elliot, K Nicholson, S Duffy, C McKenna, L Stewart, M Westwood & S Palmer.

J Burch 1,*, M Paulden 2, S Conti 2, C Stock 1, M Corbett 1, NJ Welton 3, AE Ades 3, A Sutton 4, N Cooper 4, AJ Elliot 5, K Nicholson 6, S Duffy 1, C McKenna 2, L Stewart 1, M Westwood 1, S Palmer 2

1 Centre for Reviews and Dissemination, University of York, , UK
2 Centre for Health Economics, University of York, , UK
3 Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol, , UK
4 Department of Health Sciences, University of Leicester, , UK
5 Birmingham Research Unit of the Royal College of General Practitioners, , UK
6 Department of Infection, Immunity and Inflammation, University of Leicester, , UK
* Corresponding author Email: jb67@york.ac.uk

Funding: {{metadata.Funding}}

{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}

https://doi.org/{{metadata.DOI}}

Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})

Crossmark status check

Report Content

The full text of this issue is available as a PDF document from the Toolkit section on this page.

The full text of this issue is available as a PDF document from the Toolkit section on this page.

If you would like to receive a notification when this project publishes in the NIHR Journals Library, please submit your email address below.

Responses to this report

No responses have been published.

 

If you would like to submit a response to this publication, please do so using the form below:

Comments submitted to the NIHR Journals Library are electronic letters to the editor. They enable our readers to debate issues raised in research reports published in the Journals Library. We aim to post within 14 working days all responses that contribute substantially to the topic investigated, as determined by the Editors.  Non-relevant comments will be deleted.

Your name and affiliations will be published with your comment.

Once published, you will not have the right to remove or edit your response. The Editors may add, remove, or edit comments at their absolute discretion.

By submitting your response, you are stating that you agree to the terms & conditions

An error has occurred in processing the XML document